OncoMatch/Clinical Trials/NCT02710253
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
Is NCT02710253 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for hematopoietic and lymphoid cell neoplasm.
This phase II trial studies the side effects and best dose of radiation therapy and to see how well it works in treating patients with cancer that has spread to other places in the body (metastatic) or has increased in size after being treated with immunotherapy. Giving radiation therapy may help to control the cancer after the disease has gotten worse after receiving immunotherapy in patients with cancer that has spread to the other places in the body.
Check if I qualifyExtracted eligibility criteria
Cancer type
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Non-Hodgkin Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia
Tumor Agnostic
Disease stage
Metastatic disease required
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Must have received: immunotherapy
Progressive disease via irRC on prior study or standard of care therapy utilizing an immunotherapy agent OR a clinical status that requires salvage radiation treatment
Cannot have received: radiation therapy
Exception: Allowed if high dose regions of prior and proposed radiation fields do not overlap, or overlap is only in low dose area
Has had prior radiation therapy within the past 3 months where the high dose area of the prior radiation would overlap with the high dose area of the intended radiation based on the judgment of the treating radiation oncologist.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- MD Anderson in The Woodlands · Conroe, Texas
- M D Anderson Cancer Center · Houston, Texas
- MD Anderson West Houston · Houston, Texas
- MD Anderson League City · League City, Texas
- MD Anderson in Sugar Land · Sugar Land, Texas
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify